Iomeron Injection, Solution
Product Images NDC 76381-735

21 FDA label images from Bipso Gmbh · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Iomeron (NDC 76381-735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bipso Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Iomeron 250 Carton 100 mL (Uk Iomeron 250 100ml Box)

Iomeron 250 Carton 100 mL (Uk Iomeron 250 100ml Box)
The packaging label for Iomeron 250 (Iomeprol Injection) 250 mg/mL, a contrast medium for injection administered intra-arterially, intracavernously, and intravenously. The 100 mL carton shows the brand name Iomeron prominently with the active ingredient iomeprol, and specifies 250 mg iodine per mL. The labeler is Bracco UK Ltd, located in Oxford, United Kingdom.*
FDA Label Image

Iomeron 250 Vial 100 mL (Uk Iomeron 250 100ml Label)

Iomeron 250 Vial 100 mL (Uk Iomeron 250 100ml Label)
Iomeron 250 (iomeprol) injection solution label for 100 mL. The label shows the proprietary name Iomeron 250 with the generic name iomeprol, concentration, and volume. It includes dosing details and storage instructions, as well as the Bracco logo and address. This intravascular injection solution is part of the 510-816 mg/mL strength range from labeler BIPSO GmbH.*
FDA Label Image

Iomeron 300 Carton 100 mL (Uk Iomeron 300 100ml Box)

Iomeron 300 Carton 100 mL (Uk Iomeron 300 100ml Box)
The image shows the packaging label for Iomeron 300, a contrast medium injection containing 300 mg iodine per ml. The label is for a 100 ml vial and lists Iomeprol as the active ingredient. It is intended for intravascular, intra-arterial, intraductal, intraluminal, and intravenous use. The labeler is Bracco, with an address in the United Kingdom, and includes storage instructions and a barcode.*
FDA Label Image

Iomeron 300 Vial 100 mL (Uk Iomeron 300 100ml Label)

Iomeron 300 Vial 100 mL (Uk Iomeron 300 100ml Label)
Iomeron 300 (iomeprol) injection solution label for human prescription drug, 100 mL vial. The label specifies a 300 mg iodine per mL concentration and includes regulatory and handling information. The manufacturer is BIPSO GmbH.*
FDA Label Image

Iomeron 300 Carton 200 mL (Uk Iomeron 300 200ml Box)

Iomeron 300 Carton 200 mL (Uk Iomeron 300 200ml Box)
The packaging label for Iomeron 300 (Iomeprol Injection) shows a 200 mL injection solution with 300 mg iodine per mL, indicated as a contrast medium for injection via intra-arterial, intraductal, intraluminal, and intravenous routes. The labeler is Bracco UK Ltd, with details of the solution composition and storage instructions included.*
FDA Label Image

Iomeron 300 Vial 200 mL (Uk Iomeron 300 200ml Label)

Iomeron 300 Vial 200 mL (Uk Iomeron 300 200ml Label)
Iomeron 300 injection label for Iomeprol solution, 200 mL vial. The label indicates an injection containing 300 mg/mL of Iomeprol. The packaging states it is for intravascular use and includes instructions to discard unused solution and keep out of reach of children. Manufactured by BIPSO GmbH in Oxford, UK.*
FDA Label Image

Iomeron 300 Carton 500 mL (Uk Iomeron 300 500ml Box)

Iomeron 300 Carton 500 mL (Uk Iomeron 300 500ml Box)
Packaging label for Iomeron 300 solution for injection, multi-dose container. Each 500 mL bottle contains Iomeprol 612.4 mg/mL equivalent to 300 mg iodine/mL, with excipients including trometamol, hydrochloric acid, and water for injections. The label shows dosage form as injection for intravascular use, with instructions to use automatic injector only and store below 30°C. Manufactured by Bracco UK Ltd, United Kingdom.*
FDA Label Image

Iomeron 300 Vial 500 mL (Uk Iomeron 300 500ml Label)

Iomeron 300 Vial 500 mL (Uk Iomeron 300 500ml Label)
Iomeron 300 solution for injection in a 500 ml multi-dose container. The active ingredient is Iomeprol 612.4 mg/mL, equivalent to 300 mg iodine/mL. The label includes usage instructions, storage conditions, and manufacturer information (Bracco UK Ltd, Oxford). Visible excipients include Trometamol, hydrochloric acid, and water for injections.*
FDA Label Image

Iomeron 350 Carton 100 mL (Uk Iomeron 350 100ml Box)

Iomeron 350 Carton 100 mL (Uk Iomeron 350 100ml Box)
Packaging label for Iomeron 350, an iodine-containing contrast medium injection solution with 350 mg iodine per ml. The label shows a 100 ml package, labeled for injection use in intra-arterial, intraductal, intraluminal, and intravenous applications. The product is labeled with the Bracco logo and mentions protection from light and disposal instructions. Manufacturer details list Bracco UK Ltd., Oxford, United Kingdom.*
FDA Label Image

Iomeron 350 Vial 100 mL (Uk Iomeron 350 100ml Label)

Iomeron 350 Vial 100 mL (Uk Iomeron 350 100ml Label)
Label for Iomeron 350 iomeprol injection, solution 100 mL, for intravascular use. The label includes the product name Iomeron 350 and the active ingredient iomeprol. It shows key product information including volume (100 mL) and manufacturer details (BIPSO GmbH affiliated with Bracco). Safety warnings about protection from light, disposal, and storage are noted.*
FDA Label Image

Iomeron 350 Carton 200 mL (Uk Iomeron 350 200ml Box)

Iomeron 350 Carton 200 mL (Uk Iomeron 350 200ml Box)
Packaging label for Iomeron 350, a contrast medium injection containing 350 mg iodine per mL in a 200 mL vial. The label indicates its use for intra-arterial, intraductal, intraluminal, and intravenous routes. Manufactured by Bracco UK Ltd, the label includes active ingredient details and storage instructions.*
FDA Label Image

Iomeron 350 Vial 200 mL (Uk Iomeron 350 200ml Label)

Iomeron 350 Vial 200 mL (Uk Iomeron 350 200ml Label)
Packaging label of Iomeron 350 (Iomeprol Injection) 200 mL solution for injection. The label shows the product name, strength 350 mg/mL, volume 200 mL, and manufacturer BIPSO GmbH. The label includes usage instructions and storage warnings for this intravascular pharmaceutical product.*
FDA Label Image

Iomeron 350 Carton 500 mL (Uk Iomeron 350 500ml Box)

Iomeron 350 Carton 500 mL (Uk Iomeron 350 500ml Box)
Iomeron 350 solution for injection, multi-dose container, contains Iomeprol at 714 mg/mL equivalent to 350 mg iodine per mL. The packaging indicates one 500 mL bottle for injection via intravenous route, manufactured by Bracco UK Ltd. The label includes storage instructions and usage directions, specifying use with an automatic injector only.*
FDA Label Image

Iomeron 350 Vial 500 mL (Uk Iomeron 350 500ml Label)

Iomeron 350 Vial 500 mL (Uk Iomeron 350 500ml Label)
Iomeron 350 solution for injection multi-dose container label showing a 500 mL bottle. The active ingredient is Iomeprol at 714.4 mg/mL, equivalent to 350 mg iodine/mL. The label includes usage instructions, storage conditions, lot details, and manufacturer information for Bracco UK Ltd.*
FDA Label Image

Iomeron 400 Carton 100 mL (Uk Iomeron 400 100ml Box)

Iomeron 400 Carton 100 mL (Uk Iomeron 400 100ml Box)
Iomeron 400 injection 100 mL carton label for solution containing iomeprol at 400 mg iodine per mL. The label notes it as a contrast medium for injection via intra-arterial, intraductal, intraluminal, and intravenous routes. Manufactured by Bracco UK Ltd, the packaging includes storage instructions and a barcode.*
FDA Label Image

Iomeron 400 Vial 100 mL (Uk Iomeron 400 100ml Label)

Iomeron 400 Vial 100 mL (Uk Iomeron 400 100ml Label)
Label for Iomeron 400 (iomeprol) injection solution, concentration 400 mg/mL, supplied in a 100 mL container. The label includes product information, manufacturer details (BIPSO GmbH), and usage instructions such as protection from light and disposal warnings. The packaging also features a barcode and batch/expiration information fields.*
FDA Label Image

Iomeron 400 Carton 200 mL (Uk Iomeron 400 200ml Box)

Iomeron 400 Carton 200 mL (Uk Iomeron 400 200ml Box)
Packaging label for Iomeron 400 (Iomeprol Injection) 200 mL injection solution by Bracco. It contains 400 mg iodine per mL and is a contrast medium for intravascular, intra-arterial, intraductal, intraluminal, and intravenous use. The label includes manufacturer details and storage instructions.*
FDA Label Image

Iomeron 400 Vial 200 mL (Uk Iomeron 400 200ml Label)

Iomeron 400 Vial 200 mL (Uk Iomeron 400 200ml Label)
Iomeron 400 (iomeprol) injection solution label for 200 mL container. The label indicates it contains 81.65% w/v iomeprol, 400 mg iodine/mL, with trometamol, hydrochloric acid, and water as ingredients. The product is for intravascular use and labeled by BIPSO GmbH.*
FDA Label Image

Iomeron 400 Carton 500 mL (Uk Iomeron 400 500ml Box)

Iomeron 400 Carton 500 mL (Uk Iomeron 400 500ml Box)
Packaging label for Iomeron 400 solution for injection, multi-dose container injection, 1 bottle of 500 mL. The active ingredient is Iomeprol with a concentration equivalent to 400 mg/mL iodine. The label includes usage instructions and storage information, and is labeled with the Bracco logo. The product is indicated for intravenous use.*
FDA Label Image

Iomeron 400 Vial 500 mL (Uk Iomeron 400 500ml Label)

Iomeron 400 Vial 500 mL (Uk Iomeron 400 500ml Label)
Iomeron 400 solution for injection in a multi-dose container, 500 ml bottle. The label states the active ingredient Iomeprol at 816.5 mg/ml, equivalent to 400 mg iodine/ml. It includes excipients Trome tamol, hydrochloric acid, and water for injections. The product is for intravenous use, recommended to be stored below 30°C and protected from light. Manufactured by Bracco UK Ltd, Oxford.*
FDA Label Image

Alberto Spinazzi Signature (Alberto Signature)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.